BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12605674)

  • 1. A functional polymorphism at the transcriptional initiation site in beta2-glycoprotein I (apolipoprotein H) associated with reduced gene expression and lower plasma levels of beta2-glycoprotein I.
    Mehdi H; Manzi S; Desai P; Chen Q; Nestlerode C; Bontempo F; Strom SC; Zarnegar R; Kamboh MI
    Eur J Biochem; 2003 Jan; 270(2):230-8. PubMed ID: 12605674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies.
    Horbach DA; van Oort E; Tempelman MJ; Derksen RH; de Groot PG
    Thromb Haemost; 1998 Nov; 80(5):791-7. PubMed ID: 9843173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between beta2-glycoprotein I valine/leucine247 polymorphism and anti-beta2-glycoprotein I antibodies in patients with primary antiphospholipid syndrome.
    Atsumi T; Tsutsumi A; Amengual O; Khamashta MA; Hughes GR; Miyoshi Y; Ichikawa K; Koike T
    Rheumatology (Oxford); 1999 Aug; 38(8):721-3. PubMed ID: 10501418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.
    Takeya H; Mori T; Gabazza EC; Kuroda K; Deguchi H; Matsuura E; Ichikawa K; Koike T; Suzuki K
    J Clin Invest; 1997 May; 99(9):2260-8. PubMed ID: 9151800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-directed mutagenesis of recombinant human beta 2-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipid binding and anti-cardiolipin antibody activity.
    Sheng Y; Sali A; Herzog H; Lahnstein J; Krilis SA
    J Immunol; 1996 Oct; 157(8):3744-51. PubMed ID: 8871678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-2-glycoprotein I dependent lupus anticoagulants form stable bivalent antibody beta-2-glycoprotein I complexes on phospholipid surfaces.
    Arnout J; Wittevrongel C; Vanrusselt M; Hoylaerts M; Vermylen J
    Thromb Haemost; 1998 Jan; 79(1):79-86. PubMed ID: 9459328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta2-glycoprotein I, anti-beta2-glycoprotein I, and fibrinolysis.
    Yasuda S; Atsumi T; Ieko M; Koike T
    Thromb Res; 2004; 114(5-6):461-5. PubMed ID: 15507279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between beta-2-glycoprotein I gene polymorphism and anti-beta-2 glycoprotein I antibodies in patients with multibacillary leprosy.
    Brochado MJ; Figueiredo JF; Mendes-Junior CT; Louzada-Junior P; Kim OM; Roselino AM
    Arch Dermatol Res; 2010 Oct; 302(8):583-91. PubMed ID: 20140737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism of beta2-glycoprotein I at codons 306 and 316 in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Gushiken FC; Arnett FC; Ahn C; Thiagarajan P
    Arthritis Rheum; 1999 Jun; 42(6):1189-93. PubMed ID: 10366111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variation in apolipoprotein H (beta2-glycoprotein I) affects the occurrence of antiphospholipid antibodies and apolipoprotein H concentrations in systemic lupus erythematosus.
    Kamboh MI; Manzi S; Mehdi H; Fitzgerald S; Sanghera DK; Kuller LH; Atson CE
    Lupus; 1999; 8(9):742-50. PubMed ID: 10602447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospholipid-bound beta 2-glycoprotein I induces the production of anti-phospholipid antibodies.
    Subang R; Levine JS; Janoff AS; Davidson SM; Taraschi TF; Koike T; Minchey SR; Whiteside M; Tannenbaum M; Rauch J
    J Autoimmun; 2000 Aug; 15(1):21-32. PubMed ID: 10936025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradoxical association between the 316 Trp to Ser beta 2-glycoprotein I (Beta2GPI) polymorphism and anti-Beta2GPI antibodies.
    Nash MJ; Camilleri RS; Liesner R; Mackie IJ; Machin SJ; Cohen H
    Br J Haematol; 2003 Feb; 120(3):529-31. PubMed ID: 12580974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and characterization of the human beta2-glycoprotein I (beta2-GPI) gene promoter: roles of the atypical TATA box and hepatic nuclear factor-1alpha in regulating beta2-GPI promoter activity.
    Wang HH; Chiang AN
    Biochem J; 2004 Jun; 380(Pt 2):455-63. PubMed ID: 14984368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-beta 2-glycoprotein I autoantibodies from patients with the "antiphospholipid" syndrome bind to beta 2-glycoprotein I with low affinity: dimerization of beta 2-glycoprotein I induces a significant increase in anti-beta 2-glycoprotein I antibody affinity.
    Sheng Y; Kandiah DA; Krilis SA
    J Immunol; 1998 Aug; 161(4):2038-43. PubMed ID: 9712077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valine/Leucine247 polymorphism of beta2-glycoprotein I in patients with antiphospholipid syndrome: lack of association with anti-beta2-glycoprotein I antibodies.
    Swadzba J; Sanak M; Iwaniec T; Dziedzina S; Musiał J
    Lupus; 2006; 15(4):218-22. PubMed ID: 16686261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between beta2-glycoprotein I gene polymorphisms and pediatric SLE and antiphospholipid antibodies.
    von Scheven E; Elder ME
    Lupus; 2005; 14(6):440-4. PubMed ID: 16038107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation in the apolipoprotein H (beta2-glycoprotein I) gene affects plasma apolipoprotein H concentrations.
    Mehdi H; Aston CE; Sanghera DK; Hamman RF; Kamboh MI
    Hum Genet; 1999; 105(1-2):63-71. PubMed ID: 10480357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-interaction of soluble and surface-bound beta2-glycoprotein I and its enhancement by lupus anticoagulants.
    Hayashi A; Hayashi A; Matsuura E; Suzuki K; Koike T; Hashimoto E; Takeya H
    FEBS Lett; 2008 Oct; 582(23-24):3308-12. PubMed ID: 18822289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I.
    Arnout J; Meijer P; Vermylen J
    Thromb Haemost; 1999 Jun; 81(6):929-34. PubMed ID: 10404770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-β2 glycoprotein I antibodies in complex with β2 glycoprotein I induce platelet activation via two receptors: apolipoprotein E receptor 2' and glycoprotein I bα.
    Zhang W; Gao F; Lu D; Sun N; Yin X; Jin M; Liu Y
    Front Med; 2016 Mar; 10(1):76-84. PubMed ID: 26620053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.